How to leverage digital for IVD

[Image from Unsplash]

The global in vitro diagnostics market is slated to grow some 50% over the next several years. Here’s how IVD companies can leverage digital capabilities to improve workflows, accelerate innovation and increase revenues.

Dr. Kal Patel, BrightInsight

It’s hard to overstate the importance of the global in vitro diagnostics market.

Fortune Business Insights projects the global IVD market will grow from $71 billion today to $107 billion by 2029 – a 50% increase. The National Institutes of Health estimates that 60– 70% of all healthcare decisions are influenced by IVD testing results.

According to a Deloitte report, 100% of medical technology companies reported investing in device connectivity; 77% said that integrating data from new technologies is a key challenge; and 82% said they plan to collaborate with external partners to advance their digital programs.

As wit…

Read more
  • 0

7 digital health startups you need to watch in 2021

(Image by WikiImages on Pixabay)

Digital health has skyrocketed in recent years. The pandemic has only propelled its growth by keeping patients away from doctors’ offices in droves.

Thanks to the continued adoption of smartphones, the growth of connected medical devices and changes in patients’ and providers’ preferences, digital health will only continue to expand through the 2020s and beyond, according to market researchers.

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0

BrightInsight raises another $101M for its pre-built digital health platform

BrightInsight announced today that it’s raised $101 million in a Series C round led by VC firm General Catalyst.

The money will go toward more hiring and further accelerating the work BrightInsight is conducting with customers to support their digital health product launches.

The San Jose, Calif.–based company offers a turnkey digital health platform for medtech and biopharma. BrightInsight developed its platform under a quality management system to support its customers’ global security, privacy, and regulatory requirements.

Get the full story on our sister site Medical Design & Outsourcing. 

Read more
  • 0

BrightInsight raises $101M for its pre-built digital health platform

BrightInsight announced today that it’s raised $101 million in a Series C round led by VC firm General Catalyst.

The money will go toward more hiring and further accelerating the work BrightInsight is conducting with customers to support their digital health product launches.

The San Jose, Calif.–based company offers a turnkey digital health platform for medtech and biopharma. BrightInsight developed its platform under a quality management system to support its customers’ global security, privacy, and regulatory requirements.

“This financing led by General Catalyst not only validates the market need for a global digital health platform for biopharma and medtech, but it also reinforces the tremendous progress we have made in the past year,” said Dr. Kal Patel, BrightInsight’s CEO and fo-founder.

“Our Series C round will enable BrightInsight to continue our hypergrowth and to support the development and launch of game-changing digi…

Read more
  • 0

Medtechs can’t set digital strategies aside – DTW Podcast

Digital connectivity no longer belongs in the final slides of a medtech company’s pitch deck.

In the latest DeviceTalks Weekly podcast, three leaders pushing for connected medical devices explain the need to incorporate data collection and monitoring functionality in new devices.

Scott Huennekens, who advanced the “digital surgery” strategy when he helped launch Verb Surgical, says new medtech tools must be connected to provide maximum benefit.

“If you’re making a device, you have to understand and build into it how it will be connected for that episode of care as as well as how it fits into the continuum of care,” Huennekens said in an interview with the DeviceTalks Weekly Podcast. “It just has to be part of the way you’re thinking.”

Verb Surgical, of course, is now part of Johnson & Johnson’s surgical robot product line, Ottava, which the company unveiled last year.

In a separate interview on the podcast, Mark Toland, the former CEO o…

Read more
  • 0

BrightInsight raises $40m Series B

Biopharma and medtech digital health platform provider BrightInsight announced today that it raised $40 million in a Series B financing round.

Insight Partners led the funding, while Series A investors New Leaf Venture Partners and Eclipse Ventures also participated.

According to a news release, BrightInsight plans to use the funds raised to significantly scale up team growth and international availability for its platform. Planned growth involves a new regional customer delivery center in London for supporting the company’s European clients.

Other plans include expansion in China and other Asian markets, along with investments in the company’s analytics functionalities to drive insights faster and the launch of new pre-built software assets to allow customers to enhance and accelerate digital clinical trials.

“This Series B will enable significant growth and rapid scaling for BrightInsight at a pivotal time for our company,” Bri…

Read more
  • 0

BrightInsight raises $40m Series B

Biopharma and medtech digital health platform provider BrightInsight announced today that it raised $40 million in a Series B financing round.

Insight Partners led the funding, while Series A investors New Leaf Venture Partners and Eclipse Ventures also participated.

According to a news release, BrightInsight plans to use the funds raised to significantly scale up team growth and international availability for its platform. Planned growth involves a new regional customer delivery center in London for supporting the company’s European clients.

Other plans include expansion in China and other Asian markets, along with investments in the company’s analytics functionalities to drive insights faster and the launch of new pre-built software assets to allow customers to enhance and accelerate digital clinical trials.

“This Series B will enable significant growth and rapid scaling for BrightInsight at a pivotal time for our company,” Bri…

Read more
  • 0